Pub Date : 2023-05-16eCollection Date: 2023-07-01DOI: 10.4103/tjo.TJO-D-22-00170
Ezzeldin Ramadan Ezzeldin, Akram Fekry Elgazzar, Mostafa Osman Hussein, Ezzat Nabil Abbas Ibrahim, Ehab Tharwat
Purpose: In recent years, there has been a significant shift from this destructive procedure to a reconstructive procedure such as anterior lamellar recession (ALR) and bilamellar tarsal rotation (BLTR). The aim is to report the outcomes and success rates of ALR compared to BLTR in patients with upper lid cicatricial trichiasis.
Materials and methods: Our study is a prospective, interventional, comparative study that was conducted at the Ophthalmology Department of Al-Azhar University Hospital, New Damietta, Egypt. Our study was conducted on 62 eyes of 45 consecutive patients suffering from upper lid cicatricial trichiasis that required surgical intervention (17 patients were bilateral and 28 were unilateral). Thirty-three of them were treated by ALR (group 1), and 29 of them by BLTR (group 2). All statistical analysis was performed using the SPSS version 26.
Results: As regards the immediate postoperative correction, we found that adequate correction was significantly higher in the ALR group at all follow-up periods (P < 0.05). However, the overcorrection and undercorrection were significantly higher in the BLTR group (P < 0.05). Compared to the ALR group, the BLTR group saw a greater undercorrection at 1, 3, and 6 months (9.3%% vs. 0%; P = 0.048, 18.6% vs. 1.8%%; P = 0.009, 18.6%% vs. 1.8%; P = 0.009, 18.6%% vs. 1.8%; P = 0.009, respectively).
Conclusion: ALR is better than BLTR in the treatment of upper lid cicatricial trichiasis.
目的:近年来,从这种破坏性手术到重建手术的重大转变,如前板层退缩(ALR)和双板层跗骨旋转(BLTR)。目的是报告与BLTR相比,ALR治疗上眼睑瘢痕性倒睫的疗效和成功率。材料和方法:我们的研究是在埃及新达米埃塔爱资哈尔大学医院眼科进行的一项前瞻性、介入性、比较性研究。我们的研究对象是连续45例62只眼的上眼睑瘢痕性倒睫患者,需要手术治疗(17例为双侧,28例为单侧)。ALR治疗33例(1组),BLTR治疗29例(2组)。统计学分析采用SPSS 26版。结果:在术后立即矫正方面,我们发现在所有随访期间,ALR组的矫正率明显高于ALR组(P < 0.05)。而BLTR组的过矫治和欠矫治发生率明显高于对照组(P < 0.05)。与ALR组相比,BLTR组在1、3和6个月时出现了更大的矫正不足(9.3%比0%;P = 0.048, 18.6% vs. 1.8%;P = 0.009, 18.6% vs. 1.8%;P = 0.009, 18.6% vs. 1.8%;P = 0.009)。结论:ALR治疗上睑瘢痕性倒睫优于BLTR。
{"title":"Anterior lamellar recession versus bilamellar tarsal rotation in upper lid cicatricial trichiasis.","authors":"Ezzeldin Ramadan Ezzeldin, Akram Fekry Elgazzar, Mostafa Osman Hussein, Ezzat Nabil Abbas Ibrahim, Ehab Tharwat","doi":"10.4103/tjo.TJO-D-22-00170","DOIUrl":"10.4103/tjo.TJO-D-22-00170","url":null,"abstract":"<p><strong>Purpose: </strong>In recent years, there has been a significant shift from this destructive procedure to a reconstructive procedure such as anterior lamellar recession (ALR) and bilamellar tarsal rotation (BLTR). The aim is to report the outcomes and success rates of ALR compared to BLTR in patients with upper lid cicatricial trichiasis.</p><p><strong>Materials and methods: </strong>Our study is a prospective, interventional, comparative study that was conducted at the Ophthalmology Department of Al-Azhar University Hospital, New Damietta, Egypt. Our study was conducted on 62 eyes of 45 consecutive patients suffering from upper lid cicatricial trichiasis that required surgical intervention (17 patients were bilateral and 28 were unilateral). Thirty-three of them were treated by ALR (group 1), and 29 of them by BLTR (group 2). All statistical analysis was performed using the SPSS version 26.</p><p><strong>Results: </strong>As regards the immediate postoperative correction, we found that adequate correction was significantly higher in the ALR group at all follow-up periods (<i>P</i> < 0.05). However, the overcorrection and undercorrection were significantly higher in the BLTR group (<i>P</i> < 0.05). Compared to the ALR group, the BLTR group saw a greater undercorrection at 1, 3, and 6 months (9.3%% vs. 0%; <i>P</i> = 0.048, 18.6% vs. 1.8%%; <i>P</i> = 0.009, 18.6%% vs. 1.8%; <i>P</i> = 0.009, 18.6%% vs. 1.8%; <i>P</i> = 0.009, respectively).</p><p><strong>Conclusion: </strong>ALR is better than BLTR in the treatment of upper lid cicatricial trichiasis.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 1","pages":"329-334"},"PeriodicalIF":1.1,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45488518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-05-16eCollection Date: 2024-01-01DOI: 10.4103/tjo.TJO-D-22-00148
Hamzeh Mohammad Alrawashdeh
Iris mammillations are distinctive uniform nipple-like elevations that cover the anterior surface of the iris partially or totally. It is a rare finding and may coexist with other ocular and extraocular manifestations. Optic nerve pit (ONP), also known as optic disc pit (ODP) or optic hole, is a congenital defect resulting from the failure of fetal fissure closure during the embryonic development. It belongs to the congenital cavitary anomalies spectrum. This case presents a 19-year-old female patient who complained of a gradual decrease in visual acuity in both eyes for 4 years. Slit-lamp and fundus examinations revealed iris mammillations and ODP in the left eye. Corneal topography revealed bilateral keratoconus, which was managed with cross-linking. Iris mammillations and ODP are poorly understood ocular anomalies that are not reported frequently and have never been reported previously both combined with keratoconus. Thus, ophthalmologists should be aware of these conditions, their differential diagnosis, and their possible association with other disorders. This is the first reported case of the combined coexistence of iris mammillations and ODP with keratoconus.
{"title":"An unusual coexistence of iris mammillations and optic disc pit with keratoconus: A case report and literature review.","authors":"Hamzeh Mohammad Alrawashdeh","doi":"10.4103/tjo.TJO-D-22-00148","DOIUrl":"10.4103/tjo.TJO-D-22-00148","url":null,"abstract":"<p><p>Iris mammillations are distinctive uniform nipple-like elevations that cover the anterior surface of the iris partially or totally. It is a rare finding and may coexist with other ocular and extraocular manifestations. Optic nerve pit (ONP), also known as optic disc pit (ODP) or optic hole, is a congenital defect resulting from the failure of fetal fissure closure during the embryonic development. It belongs to the congenital cavitary anomalies spectrum. This case presents a 19-year-old female patient who complained of a gradual decrease in visual acuity in both eyes for 4 years. Slit-lamp and fundus examinations revealed iris mammillations and ODP in the left eye. Corneal topography revealed bilateral keratoconus, which was managed with cross-linking. Iris mammillations and ODP are poorly understood ocular anomalies that are not reported frequently and have never been reported previously both combined with keratoconus. Thus, ophthalmologists should be aware of these conditions, their differential diagnosis, and their possible association with other disorders. This is the first reported case of the combined coexistence of iris mammillations and ODP with keratoconus.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"125-128"},"PeriodicalIF":1.1,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Osteopetrosis (OS) is a rare heritable disorder characterized by osteoclast dysfunction and increased bone density on radiography. Optic nerve osseous compression is the most frequent ocular complication of OS, with nystagmus, strabismus, ptosis, proptosis, and lagophthalmos occurring less frequently. However, it is uncommon for patients to have neurological or ocular symptoms at initial presentation. Herein, we present the case of a 3-year-old girl with the initial presentation of ocular symptoms who was confirmed to have OS through genetic testing. She was born full-term and found to have nystagmus since the age of 1 year. Her best-corrected visual acuity was 1.2/60 for both eyes. Exotropia of the left eye and bilateral small-amplitude pendular nystagmus were also noted. Color fundoscopy revealed a tessellated fundus and pale discs with cup-to-disc ratios of 0.5-0.6. Magnetic resonance imaging revealed bilateral optic canal stenosis and optic nerve atrophy. Whole-exome sequencing revealed a biallelic chloride voltage-gated channel 7 mutation, c.2297T > C (p.Leu766Pro) and c.1577G > A (p.Arg526Gln), and autosomal recessive OS was diagnosed. The patient is currently being evaluated for possible hematopoietic stem cell transplantation. We suggest that OS should be considered a differential diagnosis for unexplained nystagmus and optic nerve atrophy.
骨化症(Osteopetrosis,OS)是一种罕见的遗传性疾病,其特征是破骨细胞功能障碍和骨密度增高。视神经骨质受压是OS最常见的眼部并发症,眼球震颤、斜视、上睑下垂、眼球突出和眼睑下垂则较少发生。然而,患者最初出现神经系统或眼部症状的情况并不多见。在此,我们介绍一例最初表现为眼部症状的 3 岁女孩,她通过基因检测被确诊为 OS 患者。她足月出生,1 岁时发现眼球震颤。她的双眼最佳矫正视力为 1.2/60。同时还发现左眼外斜和双侧小振幅下垂性眼球震颤。彩色眼底镜检查显示,眼底呈棋盘格状,视盘苍白,杯盘比为 0.5-0.6。磁共振成像显示双侧视管狭窄和视神经萎缩。全外显子组测序结果显示,患者的氯离子电压门控通道7发生了c.2297T > C(p.Leu766Pro)和c.1577G > A(p.Arg526Gln)的双拷贝突变,确诊为常染色体隐性遗传性视神经萎缩症。目前正在对患者进行评估,以确定是否进行造血干细胞移植。我们建议将 OS 作为不明原因眼球震颤和视神经萎缩的鉴别诊断。
{"title":"Genetic testing confirmed osteopetrosis with initial presentation of nystagmus.","authors":"Kai-Yen Chiu, Yu-Yang Lin, Yao-Lin Liu, Ni-Chung Lee, Tzu-Hsun Tsai","doi":"10.4103/tjo.TJO-D-22-00152","DOIUrl":"10.4103/tjo.TJO-D-22-00152","url":null,"abstract":"<p><p>Osteopetrosis (OS) is a rare heritable disorder characterized by osteoclast dysfunction and increased bone density on radiography. Optic nerve osseous compression is the most frequent ocular complication of OS, with nystagmus, strabismus, ptosis, proptosis, and lagophthalmos occurring less frequently. However, it is uncommon for patients to have neurological or ocular symptoms at initial presentation. Herein, we present the case of a 3-year-old girl with the initial presentation of ocular symptoms who was confirmed to have OS through genetic testing. She was born full-term and found to have nystagmus since the age of 1 year. Her best-corrected visual acuity was 1.2/60 for both eyes. Exotropia of the left eye and bilateral small-amplitude pendular nystagmus were also noted. Color fundoscopy revealed a tessellated fundus and pale discs with cup-to-disc ratios of 0.5-0.6. Magnetic resonance imaging revealed bilateral optic canal stenosis and optic nerve atrophy. Whole-exome sequencing revealed a biallelic chloride voltage-gated channel 7 mutation, c.2297T > C (p.Leu766Pro) and c.1577G > A (p.Arg526Gln), and autosomal recessive OS was diagnosed. The patient is currently being evaluated for possible hematopoietic stem cell transplantation. We suggest that OS should be considered a differential diagnosis for unexplained nystagmus and optic nerve atrophy.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"437-440"},"PeriodicalIF":1.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: We aimed to analyze our 4-year experience of intra-arterial chemotherapy (IAC) for retinoblastoma (RB) and to examine the tumor response, globe salvage, mortality, and safety profile of IAC in the Malaysian profile.
Materials and methods: This was a retrospective, interventional case series. A total of 22 eyes of 20 patients with RB who underwent IAC using melphalan and topotecan from January 2018 to December 2021 in Hospital Kuala Lumpur were retrospectively reviewed. Tumor response, globe salvage, mortality, and safety profile of IAC were compared based on the International Classification of Retinoblastoma.
Results: The mean patient age at IAC was 21.3 months. An overall globe salvage rate of 63.6% was observed: more specifically, 100% for Group A, 75% for Groups B and C, 66.7% for Group D, and 42.9% for Group E. Poor tumor response after IAC was significantly associated with a lesser chance of globe salvage (P = 0.045). The overall rate of good tumor response following IAC was 77.3%. Specifically, rates of good tumor response in each group were 100%, 75%, 75%, 83.3% and 71.4% in group A, B, C, D and E, respectively. The mortality rate was 5%. Complications (per-catheterization) included cerebral infarct (2.2%), oxygen desaturation (2.2%), vomiting (26.1%), periorbital edema (8.8%), ptosis (6.5%), fever, femoral hematoma, and hyperpigmentation over lid (4.4% each).
Conclusion: Four-year experience showed that IAC is a safe and effective method for RB management. Patients with a poor response after IAC may have a lower chance of globe salvage. Careful patient selection is of utmost importance to achieve the best outcome in a setting of limited health-care resources.
{"title":"Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review.","authors":"Yong Zheng Wai, Dhanya Menon Radhakrishnan, Ganeshwara Lingam, Norhafizah Hamzah, Jamalia Rahmat","doi":"10.4103/tjo.TJO-D-22-00162","DOIUrl":"10.4103/tjo.TJO-D-22-00162","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to analyze our 4-year experience of intra-arterial chemotherapy (IAC) for retinoblastoma (RB) and to examine the tumor response, globe salvage, mortality, and safety profile of IAC in the Malaysian profile.</p><p><strong>Materials and methods: </strong>This was a retrospective, interventional case series. A total of 22 eyes of 20 patients with RB who underwent IAC using melphalan and topotecan from January 2018 to December 2021 in Hospital Kuala Lumpur were retrospectively reviewed. Tumor response, globe salvage, mortality, and safety profile of IAC were compared based on the International Classification of Retinoblastoma.</p><p><strong>Results: </strong>The mean patient age at IAC was 21.3 months. An overall globe salvage rate of 63.6% was observed: more specifically, 100% for Group A, 75% for Groups B and C, 66.7% for Group D, and 42.9% for Group E. Poor tumor response after IAC was significantly associated with a lesser chance of globe salvage (<i>P</i> = 0.045). The overall rate of good tumor response following IAC was 77.3%. Specifically, rates of good tumor response in each group were 100%, 75%, 75%, 83.3% and 71.4% in group A, B, C, D and E, respectively. The mortality rate was 5%. Complications (per-catheterization) included cerebral infarct (2.2%), oxygen desaturation (2.2%), vomiting (26.1%), periorbital edema (8.8%), ptosis (6.5%), fever, femoral hematoma, and hyperpigmentation over lid (4.4% each).</p><p><strong>Conclusion: </strong>Four-year experience showed that IAC is a safe and effective method for RB management. Patients with a poor response after IAC may have a lower chance of globe salvage. Careful patient selection is of utmost importance to achieve the best outcome in a setting of limited health-care resources.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"527-534"},"PeriodicalIF":1.1,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-26eCollection Date: 2024-04-01DOI: 10.4103/tjo.TJO-D-23-00009
Allan Chong-Su Tang, Swee Sew Teh, Geng-Yi Yong, Zhi-Han Tan, Xiu-Rong Yong
Bleb leakage is a notorious complication of glaucoma filtration surgery which increases the risk of sight-threatening conditions. A 25-year-old female with severe bilateral juvenile open-angle glaucoma was treated for blebitis and exogenous endophthalmitis secondary to chronic bleb leak after undergoing XEN implantation, followed by multiple rounds of bleb needling, and augmented trabeculectomy. In the right eye, visual acuity was hand movement with cataract, intraocular pressure was 6 mmHg and the bleb was large, highly elevated from 10 to 1 o'clock, avascular, thin wall, and cystic with leaking points. Combined surgery of low-setting phacoemulsification and amniotic membrane transplantation without excising and manipulating the bleb was performed in the same setting. At postoperative 1 month, 6 months, and 1 year, her right vision had improved to 6/24, and the intraocular pressure was 12-14 mmHg, and the bleb leakage had resolved. This successful treatment was accomplished by maintaining the bleb's viability, preventing additional injury, and promoting wound healing.
{"title":"The art of fixing a ticking time bomb: Combined phacoemulsification and amniotic membrane transplantation.","authors":"Allan Chong-Su Tang, Swee Sew Teh, Geng-Yi Yong, Zhi-Han Tan, Xiu-Rong Yong","doi":"10.4103/tjo.TJO-D-23-00009","DOIUrl":"10.4103/tjo.TJO-D-23-00009","url":null,"abstract":"<p><p>Bleb leakage is a notorious complication of glaucoma filtration surgery which increases the risk of sight-threatening conditions. A 25-year-old female with severe bilateral juvenile open-angle glaucoma was treated for blebitis and exogenous endophthalmitis secondary to chronic bleb leak after undergoing XEN implantation, followed by multiple rounds of bleb needling, and augmented trabeculectomy. In the right eye, visual acuity was hand movement with cataract, intraocular pressure was 6 mmHg and the bleb was large, highly elevated from 10 to 1 o'clock, avascular, thin wall, and cystic with leaking points. Combined surgery of low-setting phacoemulsification and amniotic membrane transplantation without excising and manipulating the bleb was performed in the same setting. At postoperative 1 month, 6 months, and 1 year, her right vision had improved to 6/24, and the intraocular pressure was 12-14 mmHg, and the bleb leakage had resolved. This successful treatment was accomplished by maintaining the bleb's viability, preventing additional injury, and promoting wound healing.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"275-278"},"PeriodicalIF":1.0,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11253997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-20eCollection Date: 2024-07-01DOI: 10.4103/tjo.TJO-D-22-00176
Chi-Yeh Wu, Chun-Chen Chen, Shiow-Wen Liou, Ju-Chuan Yen
This report describes a unique case of systemic diffuse large B-cell lymphoma (DLBCL) with initial ocular manifestations of bilateral optic disc edema and serous retinal detachment (SRD). A 29-year-old man presented with altered color vision in the left eye, mild fever, weakness, and headache, followed by bilaterally reduced visual acuity. Anterior segment and vitreous examinations showed no inflammation with sluggish response of light reflex. His fundus examination revealed bilateral multiple SRDs and optic disc swelling with choroidal thickening. On fluorescein angiography, pinpoint hyperfluorescence, associated dye pooling, and optic disc staining with leakage were found bilaterally. Laboratory studies revealed elevated C-reactive protein and mild leukocytosis with neutrophil predominance. He was provisionally diagnosed with probable Vogt-Koyanagi-Harada syndrome and received methylprednisolone pulse therapy. Five days later, his systemic condition deteriorated following initial ocular symptom improvement. Whole-body computerized tomography revealed clustered lymphadenopathies, which were interpreted as DLBCL after lymph node biopsy. His ocular condition improved after DLBCL chemotherapy. We hope to promote early recognition with appropriate workups through this case and literature review.
本报告描述了一例独特的全身性弥漫大 B 细胞淋巴瘤(DLBCL)病例,其最初的眼部表现为双侧视盘水肿和浆液性视网膜脱离(SRD)。一名29岁的男子因左眼色觉改变、轻度发热、乏力和头痛就诊,随后出现双侧视力下降。眼前节和玻璃体检查显示没有炎症,光反射反应迟钝。他的眼底检查显示双侧多发性色素沉着,视盘肿胀,脉络膜增厚。在荧光素血管造影检查中,发现双侧有针尖状高荧光、伴有染料汇集和视盘染色渗漏。实验室检查显示,C 反应蛋白升高,白细胞轻度增多,中性粒细胞占优势。他被初步诊断为可能患有 Vogt-Koyanagi-Harada 综合征,并接受了甲基强的松龙脉冲治疗。五天后,在最初的眼部症状改善后,他的全身状况恶化。全身计算机断层扫描发现了簇状淋巴结病变,淋巴结活检后被解释为 DLBCL。DLBCL 化疗后,他的眼部症状有所改善。我们希望通过本病例和文献回顾,促进早期识别和适当检查。
{"title":"Bilateral optic disc edema and serous retinal detachment as initial ocular manifestations of systemic lymphoma: A case report and literature review.","authors":"Chi-Yeh Wu, Chun-Chen Chen, Shiow-Wen Liou, Ju-Chuan Yen","doi":"10.4103/tjo.TJO-D-22-00176","DOIUrl":"10.4103/tjo.TJO-D-22-00176","url":null,"abstract":"<p><p>This report describes a unique case of systemic diffuse large B-cell lymphoma (DLBCL) with initial ocular manifestations of bilateral optic disc edema and serous retinal detachment (SRD). A 29-year-old man presented with altered color vision in the left eye, mild fever, weakness, and headache, followed by bilaterally reduced visual acuity. Anterior segment and vitreous examinations showed no inflammation with sluggish response of light reflex. His fundus examination revealed bilateral multiple SRDs and optic disc swelling with choroidal thickening. On fluorescein angiography, pinpoint hyperfluorescence, associated dye pooling, and optic disc staining with leakage were found bilaterally. Laboratory studies revealed elevated C-reactive protein and mild leukocytosis with neutrophil predominance. He was provisionally diagnosed with probable Vogt-Koyanagi-Harada syndrome and received methylprednisolone pulse therapy. Five days later, his systemic condition deteriorated following initial ocular symptom improvement. Whole-body computerized tomography revealed clustered lymphadenopathies, which were interpreted as DLBCL after lymph node biopsy. His ocular condition improved after DLBCL chemotherapy. We hope to promote early recognition with appropriate workups through this case and literature review.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"448-453"},"PeriodicalIF":1.0,"publicationDate":"2023-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-17eCollection Date: 2023-07-01DOI: 10.4103/tjo.TJO-D-22-00144
Hsiu-Hui Hsieh, Elizabeth P Shen
Citrobacter koseri is a rarely reported ocular pathogen. It may induce severe peripheral corneal inflammation and subsequent perforation by canaliculitis. Timely detection of the reservoir of this pathogen would halt its progression. The purpose of this study was to report a rare presentation of C. koseri chronic canaliculitis complicated with perforating peripheral ulcerative keratitis (PUK). A 71-year-old female who had several episodes of C. koseri conjunctivitis in the past 6 months was admitted to our infection ward under the impression of fever that was suspected to be related to urinary tract infection. She had concurrent copious mucopurulent discharge and blurred vision. Ocular examination disclosed hyperemic conjunctiva and an oval-shaped corneal infiltrate at 5-6 o'c periphery, which later rapidly progressed to PUK and corneal perforation. Despite aggressive treatment, the cornea continued to thin, and a second perforation occurred. After meticulous examination of the ocular adnexa, irrigation of inferior canaliculi revealed pustular discharge with profuse concretions indicating chronic canaliculitis. A cutaneous-lacrimal fistula was also found. Frequent antibiotic irrigation of the canaliculus finally halted the corneal melting and the cornea healed. Although rare, C. koseri may not only cause chronic canaliculitis but also induce peripheral corneal inflammation mimicking autoimmune-related PUK. Identification of C. koseri from conjunctival swab cultures should prompt the physicians to check chronic persistent canaliculus infections, which may help prevent rapidly progressive corneal inflammation and thus perforation. Management of C. koseri canaliculitis-induced PUK must also include antibiotic irrigation to eradicate canaliculitis infection at the reservoir and not just topical antibiotics.
{"title":"Peripheral ulcerative keratitis secondary to chronic <i>Citrobacter koseri</i> canaliculitis.","authors":"Hsiu-Hui Hsieh, Elizabeth P Shen","doi":"10.4103/tjo.TJO-D-22-00144","DOIUrl":"10.4103/tjo.TJO-D-22-00144","url":null,"abstract":"<p><p><i>Citrobacter koseri</i> is a rarely reported ocular pathogen. It may induce severe peripheral corneal inflammation and subsequent perforation by canaliculitis. Timely detection of the reservoir of this pathogen would halt its progression. The purpose of this study was to report a rare presentation of <i>C. koseri</i> chronic canaliculitis complicated with perforating peripheral ulcerative keratitis (PUK). A 71-year-old female who had several episodes of <i>C. koseri</i> conjunctivitis in the past 6 months was admitted to our infection ward under the impression of fever that was suspected to be related to urinary tract infection. She had concurrent copious mucopurulent discharge and blurred vision. Ocular examination disclosed hyperemic conjunctiva and an oval-shaped corneal infiltrate at 5-6 o'c periphery, which later rapidly progressed to PUK and corneal perforation. Despite aggressive treatment, the cornea continued to thin, and a second perforation occurred. After meticulous examination of the ocular adnexa, irrigation of inferior canaliculi revealed pustular discharge with profuse concretions indicating chronic canaliculitis. A cutaneous-lacrimal fistula was also found. Frequent antibiotic irrigation of the canaliculus finally halted the corneal melting and the cornea healed. Although rare, <i>C. koseri</i> may not only cause chronic canaliculitis but also induce peripheral corneal inflammation mimicking autoimmune-related PUK. Identification of <i>C. koseri</i> from conjunctival swab cultures should prompt the physicians to check chronic persistent canaliculus infections, which may help prevent rapidly progressive corneal inflammation and thus perforation. Management of <i>C. koseri</i> canaliculitis-induced PUK must also include antibiotic irrigation to eradicate canaliculitis infection at the reservoir and not just topical antibiotics.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 1","pages":"376-379"},"PeriodicalIF":1.1,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42194383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.4103/tjo.TJO-D-23-00012
Zhi Da Soh, Ching-Yu Cheng
The advents of information technologies have led to the creation of ever-larger datasets. Also known as big data, these large datasets are characterized by its volume, variety, velocity, veracity, and value. More importantly, big data has the potential to expand traditional research capabilities, inform clinical practice based on real-world data, and improve the health system and service delivery. This review first identified the different sources of big data in ophthalmology, including electronic medical records, data registries, research consortia, administrative databases, and biobanks. Then, we provided an in-depth look at how big data analytics have been applied in ophthalmology for disease surveillance, and evaluation on disease associations, detection, management, and prognostication. Finally, we discussed the challenges involved in big data analytics, such as data suitability and quality, data security, and analytical methodologies.
{"title":"Application of big data in ophthalmology.","authors":"Zhi Da Soh, Ching-Yu Cheng","doi":"10.4103/tjo.TJO-D-23-00012","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-23-00012","url":null,"abstract":"<p><p>The advents of information technologies have led to the creation of ever-larger datasets. Also known as <i>big data</i>, these large datasets are characterized by its volume, variety, velocity, veracity, and value. More importantly, big data has the potential to expand traditional research capabilities, inform clinical practice based on real-world data, and improve the health system and service delivery. This review first identified the different sources of big data in ophthalmology, including electronic medical records, data registries, research consortia, administrative databases, and biobanks. Then, we provided an in-depth look at how big data analytics have been applied in ophthalmology for disease surveillance, and evaluation on disease associations, detection, management, and prognostication. Finally, we discussed the challenges involved in big data analytics, such as data suitability and quality, data security, and analytical methodologies.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"123-132"},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/06/TJO-13-123.PMC10361443.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9855538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-01DOI: 10.4103/tjo.TJO-D-23-00022
Sahil Thakur, Linh Le Dinh, Raghavan Lavanya, Ten Cheer Quek, Yong Liu, Ching-Yu Cheng
Artificial intelligence (AI) has been widely used in ophthalmology for disease detection and monitoring progression. For glaucoma research, AI has been used to understand progression patterns and forecast disease trajectory based on analysis of clinical and imaging data. Techniques such as machine learning, natural language processing, and deep learning have been employed for this purpose. The results from studies using AI for forecasting glaucoma progression however vary considerably due to dataset constraints, lack of a standard progression definition and differences in methodology and approach. While glaucoma detection and screening have been the focus of most research that has been published in the last few years, in this narrative review we focus on studies that specifically address glaucoma progression. We also summarize the current evidence, highlight studies that have translational potential, and provide suggestions on how future research that addresses glaucoma progression can be improved.
{"title":"Use of artificial intelligence in forecasting glaucoma progression.","authors":"Sahil Thakur, Linh Le Dinh, Raghavan Lavanya, Ten Cheer Quek, Yong Liu, Ching-Yu Cheng","doi":"10.4103/tjo.TJO-D-23-00022","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-23-00022","url":null,"abstract":"<p><p>Artificial intelligence (AI) has been widely used in ophthalmology for disease detection and monitoring progression. For glaucoma research, AI has been used to understand progression patterns and forecast disease trajectory based on analysis of clinical and imaging data. Techniques such as machine learning, natural language processing, and deep learning have been employed for this purpose. The results from studies using AI for forecasting glaucoma progression however vary considerably due to dataset constraints, lack of a standard progression definition and differences in methodology and approach. While glaucoma detection and screening have been the focus of most research that has been published in the last few years, in this narrative review we focus on studies that specifically address glaucoma progression. We also summarize the current evidence, highlight studies that have translational potential, and provide suggestions on how future research that addresses glaucoma progression can be improved.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"168-183"},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/0f/TJO-13-168.PMC10361424.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To assess the additive potency of low-dose atropine combined with optical measures designed to decrease myopia progression.
Materials and methods: This retrospective study included 104 myopic children aged 5-12 over 4 years, divided into five groups: daily instillation of 0.01% atropine and distance single-vision spectacles (A), 0.01% atropine and progressive addition lenses (A + PAL), 0.01% atropine and soft contact lens with peripheral blur (A + CL). Two control groups were included, prescribed bifocal spectacles or single vision (SV) spectacles. Cycloplegic spherical equivalence refraction was measured biannually, including 1 year after cessation of treatment.
Results: A significant decrease in myopia progression was noted during the 2nd and 3rd years of atropine treatment: A -0.55 ± 0.55D, -0.15 ± 0.15, -0.12 ± 0.12D were 1st, 2nd, 3rd years, respectively, A + PAL -0.47 ± 0.37D, -0.10 ± 0.25D, and -0.11 ± 0.25D were 1st, 2nd, 3rd years, respectively, A + CL -0.36 ± 0.43D, -0.13 ± 0.29D, and -0.10 ± 0.27D were 1st, 2nd, 3rd years, respectively. Myopia progression over 3 years, respectively, was -0.82 ± 0.50D, -0.70 ± 0.69D, -0.59 ± 0.66D in the bifocal group and -1.20 ± 1.28D, -0.72 ± 0.62D, -0.65 ± 0.47D in the SV group. One year after cessation of atropine treatment, myopia progression was - 0.32 ± 0.31D in A, -0.23 ± 0.28D in A + PAL, and -0.18 ± 0.35D in A + CL.
Conclusion: Atropine 0.01% presented as effective at decelerating myopia progression, more prominent in the 2nd and 3rd years of treatment. Combining atropine 0.01% with optical modalities exhibited a trend for added efficacy over monotherapy. A + CL exhibited the least rebound effect 1 year after cessation of treatment.
目的:评价低剂量阿托品联合光学措施降低近视进展的加性效价。材料与方法:回顾性研究104例5-12岁的4岁以上近视儿童,将其分为每日滴注0.01%阿托品加远距单视眼镜(A)、0.01%阿托品加渐进镜片(A + PAL)、0.01%阿托品加周围模糊软性隐形眼镜(A + CL) 5组。包括两个对照组,处方双焦点眼镜或单视力(SV)眼镜。每半年测量一次睫状体麻痹的球等效屈光度,包括停止治疗后1年。结果:在阿托品治疗的第2年和第3年,近视进展明显降低:A -0.55±0.55D, -0.15±0.15,-0.12±0.12D分别为第1、2、3年,A + PAL分别为-0.47±0.37D, -0.10±0.25D, -0.11±0.25D, A + CL分别为-0.36±0.43D, -0.13±0.29D, -0.10±0.27D分别为第1、2、3年。双焦点组3年近视进展分别为-0.82±0.50D、-0.70±0.69D、-0.59±0.66D, SV组3年近视进展分别为-1.20±1.28D、-0.72±0.62D、-0.65±0.47D。停止阿托品治疗1年后,A组近视进展为- 0.32±0.31D, A + PAL组为-0.23±0.28D, A + CL组为-0.18±0.35D。结论:0.01%阿托品具有明显的减缓近视进展的作用,在治疗第2年和第3年更为显著。0.01%阿托品联合光学治疗比单药治疗有增加疗效的趋势。A + CL在停药1年后反弹效应最小。
{"title":"Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study.","authors":"Nir Erdinest, Naomi London, Itay Lavy, Nadav Levinger, Eran Pras, Yair Morad","doi":"10.4103/tjo.tjo_31_22","DOIUrl":"https://doi.org/10.4103/tjo.tjo_31_22","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the additive potency of low-dose atropine combined with optical measures designed to decrease myopia progression.</p><p><strong>Materials and methods: </strong>This retrospective study included 104 myopic children aged 5-12 over 4 years, divided into five groups: daily instillation of 0.01% atropine and distance single-vision spectacles (A), 0.01% atropine and progressive addition lenses (A + PAL), 0.01% atropine and soft contact lens with peripheral blur (A + CL). Two control groups were included, prescribed bifocal spectacles or single vision (SV) spectacles. Cycloplegic spherical equivalence refraction was measured biannually, including 1 year after cessation of treatment.</p><p><strong>Results: </strong>A significant decrease in myopia progression was noted during the 2<sup>nd</sup> and 3<sup>rd</sup> years of atropine treatment: A -0.55 ± 0.55D, -0.15 ± 0.15, -0.12 ± 0.12D were 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> years, respectively, A + PAL -0.47 ± 0.37D, -0.10 ± 0.25D, and -0.11 ± 0.25D were 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> years, respectively, A + CL -0.36 ± 0.43D, -0.13 ± 0.29D, and -0.10 ± 0.27D were 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> years, respectively. Myopia progression over 3 years, respectively, was -0.82 ± 0.50D, -0.70 ± 0.69D, -0.59 ± 0.66D in the bifocal group and -1.20 ± 1.28D, -0.72 ± 0.62D, -0.65 ± 0.47D in the SV group. One year after cessation of atropine treatment, myopia progression was - 0.32 ± 0.31D in A, -0.23 ± 0.28D in A + PAL, and -0.18 ± 0.35D in A + CL.</p><p><strong>Conclusion: </strong>Atropine 0.01% presented as effective at decelerating myopia progression, more prominent in the 2<sup>nd</sup> and 3<sup>rd</sup> years of treatment. Combining atropine 0.01% with optical modalities exhibited a trend for added efficacy over monotherapy. A + CL exhibited the least rebound effect 1 year after cessation of treatment.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"231-237"},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/51/TJO-13-231.PMC10361442.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9855536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}